Molecular markers of early Parkinson's disease based on gene expression in blood
about
Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s DiseaseThe promise of neuroprotective agents in Parkinson's diseaseCharacterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencingPredictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsBlood gene expression profiling detects silica exposure and toxicityA Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityChaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by HipPGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesTargeting heat shock proteins to modulate α-synuclein toxicityMolecular chaperones and co-chaperones in Parkinson diseaseBiomarkers of postoperative delirium and cognitive dysfunctionBiochemical premotor biomarkers for Parkinson's diseaseEmerging candidate biomarkers for Parkinson's disease: a reviewDEGAS: de novo discovery of dysregulated pathways in human diseasesBlood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease PatientsThe effect of listening to music on human transcriptomeCOEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH)Heat shock proteins in neurodegenerative disorders and agingDexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patientsEpigenetic and immune function profiles associated with posttraumatic stress disorder.Quantifying the white blood cell transcriptome as an accessible window to the multiorgan transcriptome.Knowledge Driven Variable Selection (KDVS) - a new approach to enrichment analysis of gene signatures obtained from high-throughput dataPlasma apolipoprotein A1 as a biomarker for Parkinson diseaseExpression data analysis to identify biomarkers associated with asthma in children.Factors affecting the accuracy of a class prediction model in gene expression data.Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.Network-based support vector machine for classification of microarray samples.A cross-study transcriptional analysis of Parkinson's disease.Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patientsMetabolomic profiling in LRRK2-related Parkinson's diseaseEvidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson diseaseSRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.Deficits in bioenergetics and impaired immune response in granulocytes from children with autismSupport Vector Machines with Disease-gene-centric Network Penalty for High Dimensional Microarray Data.Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseBlood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.Blood-based biomarkers for Parkinson's diseaseBiomarkers for cognitive impairment in Parkinson disease.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.
P2860
Q21090572-8F8C9CF2-AE0C-4C50-B923-18321C8CA6A1Q21129436-888988E4-BE7A-4399-9F6C-F64A49888202Q21131890-35D84E5C-44CE-4553-A662-3B3029272206Q21183974-7154E2BD-78B2-4892-A4BB-AEDB3E04328AQ23919914-3C8A0239-EB76-4BD0-A2F8-22B2DA602725Q24296968-762CA060-DDA3-4E87-BBE9-166DDA34A7B2Q24312452-8C3A234A-9B0E-4B4B-8043-91E50465C3D1Q24597726-16A19A5B-14B0-4F1E-A7DC-8E53D56A7263Q24650014-046B5B39-EE8B-413A-9501-BDC277A924B4Q26827066-34791BCA-768F-4E26-A59B-EAE9B1CB1C3EQ26828834-6896526F-AA8E-46AE-B7CE-5DEFE2B0ED61Q26830796-778ADCBE-5A9E-469E-B4ED-E6B4BF75EC34Q27008467-C2155E26-9340-4AAA-9AAF-CA16575FB5B7Q27015018-FE716CF4-3DFA-4D7E-A427-E527D086709DQ28475850-629EA980-CC76-4F42-81E4-432C166237AFQ28550937-FF1295FE-AF08-4C62-8EC3-ADD348583AE0Q28652292-169B5A99-7AA3-4C64-8AA8-9F6E532126A1Q28818101-A766DEBA-2C06-4665-8DFB-84C109D52335Q30414556-DCDB5DDE-4950-4277-AF28-1BBC7C318A4AQ30455078-08964515-6F9A-40FB-BBCA-DF28315F5DA5Q30478641-6E5D3CB1-E27B-4495-832B-8C1303BF01EBQ30505781-CFC66D8C-8A39-4B7F-9396-9BCD701D5288Q30537896-D4FA5F11-39C5-4587-A174-CB12B5CB57B5Q30544798-5891D675-78BB-482F-9D28-1F670E783AC5Q30813335-ED3A0C9D-AB4C-4991-84B4-2FB0A970B874Q30975559-A13FA814-6324-4B11-8E14-DA2B61E81B84Q33389138-0A49204A-C51C-4A44-BF26-CBC86F13F744Q33407778-CF2B4ABA-99B1-4F4E-96BD-43D1A20DFD16Q33420377-91BA574B-89D9-499F-B301-B99C4F1E8C72Q33497640-4B464E42-DF21-4467-BA9C-B9ADE6B3250CQ33511761-485CD078-E9CF-49EA-B6E8-244185607BDBQ33527392-D3116060-E96C-44F0-BC34-83ABC75EEA51Q33531733-C82F8BA8-722B-4CF4-89E2-6DF7AFA7E9BAQ33551727-F286574C-AD65-403D-81B3-ABFBD4507F27Q33558619-A2A2FF78-2D72-4F55-B2E4-1F46D356CDA8Q33726762-BB874D50-0C75-4349-AB81-7298E5A2CEDDQ33746261-3AB3EC73-A3F9-489D-8BD0-36B910A250BBQ33804255-0C9A9A2A-E925-458E-9E6F-D0CDACB7BEB1Q33896664-B5734853-4402-4F90-8A90-9909E6311FABQ34032608-2EB77FC2-A486-4A0B-8656-3481355A7738
P2860
Molecular markers of early Parkinson's disease based on gene expression in blood
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Molecular markers of early Parkinson's disease based on gene expression in blood
@ast
Molecular markers of early Parkinson's disease based on gene expression in blood
@en
Molecular markers of early Parkinson's disease based on gene expression in blood
@en-gb
Molecular markers of early Parkinson's disease based on gene expression in blood
@nl
type
label
Molecular markers of early Parkinson's disease based on gene expression in blood
@ast
Molecular markers of early Parkinson's disease based on gene expression in blood
@en
Molecular markers of early Parkinson's disease based on gene expression in blood
@en-gb
Molecular markers of early Parkinson's disease based on gene expression in blood
@nl
prefLabel
Molecular markers of early Parkinson's disease based on gene expression in blood
@ast
Molecular markers of early Parkinson's disease based on gene expression in blood
@en
Molecular markers of early Parkinson's disease based on gene expression in blood
@en-gb
Molecular markers of early Parkinson's disease based on gene expression in blood
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Molecular markers of early Parkinson's disease based on gene expression in blood
@en
P2093
Clemens R Scherzer
Daniel Fefer
John H Growdon
Joseph J Locascio
Lee J Morse
Lewis R Sudarsky
Michael A Hauser
Roderick V Jensen
Steven R Gullans
Zhixiang Liao
P2860
P304
P3181
P356
10.1073/PNAS.0610204104
P407
P50
P577
2007-01-16T00:00:00Z